Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open-label extension of a randomized, double-blind, placebo controlled trial

Joel Kremer, Mark Genovese, Grant W. Cannon, Jacques Caldwell, John Cush, Daniel E. Furst, Michael Luggen, Ed Keystone, Joan Bathon, Arthur Kavanaugh, Eric Ruderman, Patricia Coleman, David Curtis, Elliott Kopp, Seth Kantor, Michael Weisman, Jonathan Waltuck, Herbert B. Lindsley, Joseph Markenson, Bruce CrawfordIndra Fernando, Karen Simpson, Vibeke Strand

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open-label extension of a randomized, double-blind, placebo controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences